Search research articles
Contact Us
Filters
Showing results (11-20 of 49) with videos related to
Page
of 5
Sort By:
American Journal of Physiology. Renal Physiology
|
February 3, 2017
Primary proximal tubule hyperreabsorption and impaired tubular transport counterregulation determine glomerular hyperfiltration in diabetes: a modeling analysis
K Melissa Hallow, Yeshitila Gebremichael, Gabriel Helmlinger, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
March 21, 2018
Assessing QT/QTc interval prolongation with concentration-QT modeling for Phase I studies: impact of computational platforms, model structures and confidence interval calculation methods
Jingtao Lu, Jianguo Li, Gabriel Helmlinger, et al.
Frontiers in Oncology
|
September 28, 2020
Quantification of Scheduling Impact on Safety and Efficacy Outcomes of Brain Metastasis Radio- and Immuno-Therapies: A Systematic Review and Meta-Analysis
Veronika Voronova, Svetlana Lebedeva, Marina Sekacheva, et al.
Frontiers in Immunology
|
May 18, 2026
Quantitative systems pharmacology model of B cell immune response in mouse
Yaroslav Ugolkov, Alina Volkova, Gabriel Helmlinger, et al.
Frontiers in Pharmacology
|
May 27, 2026
Niraparib PBPK modeling to predict optimal dosage in patients with hepatic impairment
Anatoly Pokladyuk, Veronika Voronova, Gabriel Helmlinger, et al.
Drug Metabolism and Pharmacokinetics
|
March 3, 2009
Modeling and simulation of preclinical cardiac safety: towards an integrative framework
Antoine Soubret, Gabriel Helmlinger, Bérengère Dumotier, et al.
Frontiers in Cardiovascular Medicine
|
February 2, 2024
Optimization of the MACE endpoint composition to increase power in studies of lipid-lowering therapies-a model-based meta-analysis
Alina Volkova, Boris Shulgin, Gabriel Helmlinger, et al.
Cancer Chemotherapy and Pharmacology
|
April 26, 2019
Resistance models to EGFR inhibition and chemotherapy in non-small cell lung cancer via analysis of tumour size dynamics
Hitesh B Mistry, Gabriel Helmlinger, Nidal Al-Huniti, et al.
Frontiers in Immunology
|
May 29, 2019
Quantitative Mechanistic Modeling in Support of Pharmacological Therapeutics Development in Immuno-Oncology
Kirill Peskov, Ivan Azarov, Lulu Chu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2002
Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism
Gabriel Helmlinger, Axel Sckell, Marc Dellian, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 49) with videos related to
Sort By:
Page
of 5
American Journal of Physiology. Renal Physiology
|
February 3, 2017
Primary proximal tubule hyperreabsorption and impaired tubular transport counterregulation determine glomerular hyperfiltration in diabetes: a modeling analysis
K Melissa Hallow, Yeshitila Gebremichael, Gabriel Helmlinger, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
March 21, 2018
Assessing QT/QTc interval prolongation with concentration-QT modeling for Phase I studies: impact of computational platforms, model structures and confidence interval calculation methods
Jingtao Lu, Jianguo Li, Gabriel Helmlinger, et al.
Frontiers in Oncology
|
September 28, 2020
Quantification of Scheduling Impact on Safety and Efficacy Outcomes of Brain Metastasis Radio- and Immuno-Therapies: A Systematic Review and Meta-Analysis
Veronika Voronova, Svetlana Lebedeva, Marina Sekacheva, et al.
Frontiers in Immunology
|
May 18, 2026
Quantitative systems pharmacology model of B cell immune response in mouse
Yaroslav Ugolkov, Alina Volkova, Gabriel Helmlinger, et al.
Frontiers in Pharmacology
|
May 27, 2026
Niraparib PBPK modeling to predict optimal dosage in patients with hepatic impairment
Anatoly Pokladyuk, Veronika Voronova, Gabriel Helmlinger, et al.
Drug Metabolism and Pharmacokinetics
|
March 3, 2009
Modeling and simulation of preclinical cardiac safety: towards an integrative framework
Antoine Soubret, Gabriel Helmlinger, Bérengère Dumotier, et al.
Frontiers in Cardiovascular Medicine
|
February 2, 2024
Optimization of the MACE endpoint composition to increase power in studies of lipid-lowering therapies-a model-based meta-analysis
Alina Volkova, Boris Shulgin, Gabriel Helmlinger, et al.
Cancer Chemotherapy and Pharmacology
|
April 26, 2019
Resistance models to EGFR inhibition and chemotherapy in non-small cell lung cancer via analysis of tumour size dynamics
Hitesh B Mistry, Gabriel Helmlinger, Nidal Al-Huniti, et al.
Frontiers in Immunology
|
May 29, 2019
Quantitative Mechanistic Modeling in Support of Pharmacological Therapeutics Development in Immuno-Oncology
Kirill Peskov, Ivan Azarov, Lulu Chu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2002
Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism
Gabriel Helmlinger, Axel Sckell, Marc Dellian, et al.
Page
of 5